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Summary Statement:
During the past nine (9) months we have continued our studies along the following
lines:
1. Further development of techniques for and the instrumentation of dogs and
other animals including primates in a manner compatible with the 16ng term
survival (300 + days) and periodic study (biweekly) of cardiac dynamics in
these conscious and healthy instrumented animals.
II. Studies on the effect of temporary application (1-15 mins.) of lower body
negative pressure (LBNP-40) of between -30 and -50 mm Hg. on cardiac
dynamics.
III. Continued studies on the effect of infusing selected drugs on ventricular
performance. An effort was made to determine the "validity" of ventricular
function changes in conscious instru'nented animals, such as:
A.' The validity of using "pacing" of the left ventricle to secure the
data for construction of reliable ventrieular function curves for
conscious instrumented dogs.
B. Evaluation of the reliability of various techniques for identifying
myoca rd ia I contracti Ii ty changes.
(1) dP/dt/developed LVP.
(2) Shifts in ventricular function curves.
(3) Changes in mean'!CF.
(4) Changes in the end-systolic volume/end-systolic pressure
relation.
C. Defining the "typical" effect of constant infusions of norepinephrine,
isoproterenol, angiotensin II, methoxamine, phenylephrine on cardiac
dynamics in conscious instrumented dogs.
/
IVo Further development of a computer based data acquisition and reduction system.
A. Programs for cardiac cycle definition, calculation of derived variables,
and techniques for data reduction involving "large samples (4 mins.)
containing 200 or more consecutive cardiac cycles.
Vo Continued development of a totally implantable package of biosensors for the
semicontinuous telemetering of the primary variables, left ventricular pressure,
aortic pressure, left ventricular internal diameter, and the left ventricular
electrogram. This system is designed to permit studies in conscious primates
(chimpanzees).
VI. Initiated studies on the effects of right and left atrial stretch receptor
stimulation on myocardial function and renal function in conscious instru-
mented dogs.
VII. 'Initiated a systematic study to evaluate the validity of the use of certain
popularized non-invasive techniques for evaluating ventricular function by
correlating these indices with the hemodynamic Information that is derived
from the simultaneously monitored primary variables in conscious instrumented
dogs.
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I. Further Development of Techniques for and the Instrumentation of Dogs and Other
Animals in a Manner Compatible with the Long Term Survival (300 + days) and
Periodic Study (biweekly) of Cardiac Dynamics•.
Figure 2 shows a diagram of our usual instrumentation. Table 1 summarizes control
- data for dogs of this type, taken an average of 101 days after instrumentation. The
techniques for instrumenting dogs in this way have been described in the main body of
our grant application and published articles. (See section on Publications)
In this area we have concentrated our attack during the past year on monitoring
simultaneously the instantaneous changes in ascending aortic flow, left ventricular
pressure, aortic pressure, left ventricular internal diameter, left ventricular aorta to
apex length, the left atrio-ventricular electrogram, and dP/dt that occur in conscious
instrumented dogs throughout each of a series of consecutive cardiac cycles (usually
200 or more). Figure 1 shows a typical analog record of three consecutive cardiac
cycles recorded from one such instrumented dog (# 162). This is a portion 6fa record
made from this dog sixty-five (65) days after surgery for instrumentation.
The main purposes of these studies stemmed from the needs; (1) for more precise
information concerning the limits and constraints in the use' of a single dimensional
measurement, specifically left ventricular internal diameter (LVI D), for estimating
the moment to moment changes in internal volume of the left ventricle, (2) to com-
pare the values for stroke volume obtained using an electromagnetic flowmeter to
those calculated from dimensional measurements, (3) to define the changes occuring
in the axis ratio left ventricular length (LVL) divided by LVID (LVVLVID) through-
out the cardiac cycle in a number of instrumented conscious dogs both during control
periods and under a variety of experimental conditions.
Figure 3 shows a calibrated plot of the dimensional changes - axis ratio (L/ D),
LVL, LVID, calculated internal volume - along with the changes occuring in aortic
and ventricular pressures, and ascending aortic flow for the periods of atrial con-
traction (AC), isovolumic contraction (lVC), ejection, and rapid filling for a single
cardiac cycle recorded from an instrumented dog.
The data in figure 4 was calculated from recordings mode on dog #162 of the type
shown in figure 1. The relation between the changes in length and changes in internal
diameter shown in this data (figs. 3 and 4) are characteristic of our findings. We
have data on hundreds of cardiac cycles taken from each of six (6) dogs where length
was recorded as shown in figure 1. The data is being collected during control periods
and during periods of infusion of various drugs, increasing heart rate by pacing, and
rapid infusions of dextran. Thus far it appears that these interventions do not affect
the pattern of change in VD (fig. 4) during ejection.
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The relation of change in ventricular length to change in internal diameter during
ejection for a single cycle is shown in the lower half of figure 4. When this relation
was plotted for each of a large number of (100 +) cardiac cycles in this dog, the average
slope of the regression line for the data was found td be 0.4 + 0.014 (5. D.) showing
that this slope remained extremely constant. Likewise the slope was not changed by a
.. variety of interventions such as infusions of norepinephrine, isoproterenol, and
angiotensin II or pacing the ventricle. The slope of this relation was found to
be the same for all the dogs studied so far. These data suggest that the changes in
left ventricular length occurring during ejection in healthy conscious dogs are
predictable from a knowledge of the simultaneous changes occurring in left ventri-
cular diameter. Although measurements of both lVl and lVID simultaneously is the
desired means of uti Iizing dimensional methods for estimating left ventricular volume
changes from moment to moment, the extrapolation of volume changes from measure-
ments of internal diameter alone seems to be feasible, if changes in the length
dimension are small and can be predicted from diameter changes during ejection.
We feel that this is an important observation especially since the use of sonar-
micrometry has become a popular non-invasive technique for estimating ventricular
dimensional and volume changes in man.
We are currently still aralyzing this data and evaluating the implications to be
derived from them.
We have compared the values for stroke volume derived from aortic flow measure':'
ment (electromagnetic flow meter) to the stroke volume calculated from the simul-
taneously monitored dimensional changes (lVl + lVID) for the same cardiac cycle.
With th~ aid of the computer and a specially developed data reduction program we
are a~le to make these calculations for ,large numbers of consecutive cardiac cycles
while recording from each instrumented animal. There is a good correlation between
the values for stroke volume calculated by the two methods. This data is now being
collated and summarized. Our results in this regard are in agreement with those of
Mitchell and Associates, Bishop and Associates and MacDonald.
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II 0 Studies on the Effect of Temporary Application (1-15 mins) of Lower Body Negative
Pressure (LBNP-40) of Between -30 and -50 mm Hg. on Cardiac Dynamics.
The cardiovascular adjustments to LBNP have been previously studied in humans and
.. anesthetized dogs. However, no studies have been carried out in conscious animals.
Recently Nutter, Hurst, and Murray (J. Appl. Physiol. 26: 23, 1969) studied the changes
in left ventricular function in intact anesthetized dogs during graded hypovolemia
produced by exposure to -30, -60, -90 mm Hg. lower body negative pressure. They
observed, in twelve (12) dogs, a linear decrease in left ventricular pressure, max
dP/dt, ejection fraction, aortic flow, peak power and stroke work. Of interest was
their finding that myocardial contractility, as measured by max dP/dt/isovolumic
pressure and max dF/dt to peak flow, was not altered by moderate hypovolemia. We
were interested in studying the effects of LBNP in conscious instrumented dogs with the
objective of characterizing the responses to LBNP in conscious animals so that it maybe
used as a calibrated forcing function on the cardiovascular system; and alse to study
the effect of various pressor, inotropic and blocking agents on the response of the cardio-
vascular system to lower body negative pressure.
Five (5) conscious instrumented dogs were subjected to moderate levels (-40 to -50
mm Hg) of lower body negative pressure. A specially constructed lower body negative
pressure chamber was made from thick-walled plexiglass and a steel frame. This
chamber is capable of withstanding pressures of at least -90 mm Hg. The chamber is
fitted with an iris type gum rubber seal. An exhaust is provided at the side which is
connected to one or two commercial type vacuum cleaners. An outlet is provided
which allows for the measurement of pressures in the chamber when the animal is
subjected to lower body negative pressure. The hind quarters of the dog are placed
in the box and sealed at the mid-abdominal level when it was desired to expose the
animal to LBNP.
Conscious dogs were submitted to LBNP (-40 mm Hg) before and after (1) beta
receptor blockade with propranolol (2) mild sedation with Inovar* 0
The cardiovascular responses to moderate LBNP in conscious dogs has been found
to be variable. Figure 5 shows a recording of the response from dog #151 without
sedation. Upon application of LBNP (-45 mm Hg) there is a marked reduction in left
ventricular end-diastolic and end-systolic size, a reduction in effective end-diastolic
pressure and systolic LV pressure, an initial decrease in aortic systol ic and diastolic
pressure, an increase in max dP/dt and a marked increase in heart rate. The main-
tanance of an elevated max dP/dt and gradual return of heart size and aortic pressure
is also seen. Analysis of the data for four (4) additional animals is shown in figures
6 through 9 and tables 2 - 5. It can be seen from these data that in all cases there·
was a reduction in end-diastolic and end-systolic and stroke volumes. The amount
of change v(lried from animal to animal.
*Pitman-Moore, Washington Crossing, New Jersey
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The changes in total peripheral resistance (TPR) can be seen in figures 6 through
9. The increase in TPR varies from 4% to 38%. Cardiac output was decreased in all
animals by 18 to 3()o~ except in one animal, dog #151 where there was an increase
in C.Oo by 13%. In the studies, changes in myocardial contractility were estimated
from dP/dt with relation to a given developed pressure during the phase of isovolumic
_ contraction (dP/dt/PO) and the mean velocity of circumferential fiber shortening
(XVCF) during the phase of ejection. Both of the indices usually show variable
increases during the responses to LBNP. Again the changes in heart rate though
markedly increased in dog #151 show the same degree of variability from animal
to animal in response to LBNP.
Beta receptor blockade was obtained in each animal through administration of
enough propranolol (usually 0.5 mglKg body wt., I. V.) to block the observed
response to standard doses of isoproterenol (usually 10"AJg) in a single injection.
Figures 6, 7, and lOB show the cardiovascular effects of beta-adrenergic blockade
in the conscious dog. There is an increase in TPR, and generally an increase in
left ventricular end-diastolic size and end systolic size, a decrease in heart rate
and no significant changes in myocardial contractility was measured.
The dynamic recording of the response after beta adrenergic blockade is shown
in figure 8•. There is a uniform decrease in left ventricular end-diastolic and ~nd­
systolic volume, a· slight decrease in aortic pressure and no change in heart rate,
in addition, there is no change in myocardial contractility. However after
propranolol most dogs demonstrated an elevation of total peripheral resistance,
with a reduction in the ejected fraction and reduction in stroke work at the same
level of LBNP as that for the control period.
These preliminary observations would lead to the conclusion that the cardio-
vascular responses seen to lower body negative pressure appear to be dependent
on the level of understanding of autononic nervous activity. For in the conscious
dog varied responses were obtained; while in the dog under mild sedation or beta
receptor blockade the responses were relatively uniform and similar to those
reported for the anesthetized animals. Further studies are being conducted to
further understand the responses reported here.
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TABLE 2
Effect of LBNP on Cardiac Function Before and After Propranolol - Oog # 151
.. Control After Propranolol
Variable Contro (Cl) LBNp: Control (C2) LBNP
N-l57 N- 188 %Cl N-74 % C1 N- 58 %C2
TPR 2.4 2.6 :.8 2.6 8 3.9 50
MAP 128+8' :) 145+10 13 139 + 13 9 137+9 -1
.-
- - -EOV 65 +3 62+6
-5 70+4 8 66+5 -6
- - - -.
ESV " 24 +2 23+3 -4 28+3 17 . 30+2 +7 :
- - - -
SV 41 +3 :'39+5' ..-5 42+3 2 36+5 -14
- - -EJF 63+3 '63+4 0 59 +3 -6 55 +5 -7
- -
_.
C.O. 3.9 4.4 +13 3.9 0 2.7 -31
LVEOP 8+3 0.1+5 -99 12~+3 50 . 3.0+ 6 -75
- - - -
HR 99+16 121 + 28 +22 96 T,12 -3 82+24 -15
- - - -
.
EJT 171 + 5 152 +9
-11 172+4 0.6 170+8 -1
- - - -
dP/dt/P O 79+9 108+21 37 74+9 -6 64+9 -14
- - - -
'fOP/dt 2975+75 3855+532 :30 2753 + 159 -7 2492 +213 -10 .
- - - -
SW 83+7 88+14 6 89 +7 +7 79+12 -11
- - - -
VCF 1.7 +0. 1 2.0+0.2 18' 1.6 +0. 1 -6 1.5+0.1 -6 .
- - - -
, ..
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oTABLE 3
. Effects of LBNP (-45mm Hg) on Cardiac Function - Dog # 155
-
Variable Control LBNP LBNP after Propranolol
N=423 % Control N=307 . % Control
TPR 3.2 5.2 62.5 4.5 40.6
MAP 104 +12 126. 21.2 147.5 41.8
-
EOV 63:.7+7 . 39.8 -37.5 68.0 6.8
..
ESV 25.0+2 . 19 .. 2 -23.2 33.0 . 32.0
SV 38.6+ 7 20.6 -46.6 35.0 -9.3
-
EJF 60.3 +5 48.8 -19. 1 51.4 -14.8
C.O. 2.5+ 2.2 -12.0 2.7 8.0
LVEOP 1.6+2 -16.2 -5.7
-
HR 81.3 +36 122 0 ' +50.] 85.8 5.5
EJT 184.3+ 140.5 -24 178.0 -3.3
-
DP/dt/PO 50+10 67.3 -.34 53.2 5.9
-
tOP/dt 1970+294 2577.0 30.8 21.0 6.8
.",-
SW 67.4+ 16 38.6 -42.7 77.0 14.2
-
XVCF 18.2+1.6 . 13.2 -27.5 . 13.9 -23.6·
-
AvWFej 1735+248 1423.0 -18.0 2418.6 39.0
-
.i'
'. :.
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III. Continued studies on the effect of infusing selected drugs on ventricular performance
An effort was made to determine the II validity ll of ventricular function changes in
conscious instrumented animals, such as:
A. The validity of using llpacing ll of the left ventricle to secure the data for
construction of reliable ventricular function curves for conscious instrumented
dogs.
B. Evaluation of the reliability of various techniques for identifying myocardial
contracti Ii ty changes.
(l)dP/dt/developed lVP.
(2) Shifts in ventricular function curves.
(3) Changes in mean VCF.
(4) Changes in the end-systolic volume/end-systolic pressure relation.
C. Defining the t1typicalll effect of constant infusions of norepinephrine, isopro-
terenol, angiotensin II, methoxamine, phenylephrine on cardiac dynamics
in conscious instrumented dogs.
A preliminary survey of the cardiac dynamic effects of single injections and constant
infusions of various concentrations of five well known drugs has been made. Summaries
of our general observations with examples of our initial data are presented below in
five (5) sections~ These data are presented only to demonstrate the type of data
acquisition and the kind of information that can be secured from our instrumented dogs
using the computer and one of the programs for data acquisition and reduction which
we are developing.
The purposes of these studies are summarized in our IISummary Statement ll above.
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_ Effect of single injection of norepinephrine (0.4 mgms/kg.)
A classical response to a single intravenous injection of norepinephrine into
a conscious instrumented dog is seen in figure 10. This dog was in excellent health
and was studied 60 days after surgery for instrumentation. With the aid of our
digital computer each cardiac cycle occurring in the interval indicated in figure 10: ..
was analyzed•. The data plotted in figure 11 was taken during the· recording shown .....
in figure 10. In figure 11 we have plotted the changes occurring in the indicated
selected variables for every other cardiac cycle starting with the 90th cardiac
• < ,., -
cycle from the start of the computer sampling thru the 150th cycle. As a result
figurell glves a profile of the pattern of change that occurs in the key variables
indicative of cardiac and vasclJla.r performance in response to a single intravenous .
injection of a commonly used dose of norepinephrine.
This plot (fig. 11) shows that the norepinephrine injection rapidly increased
the myocardial contraCtility index dP/dt/P, as well as mean arterial pressure•.
In addition, stroke work (~), stroke power (SP), and stroke volume (SV) were
also increased simultaneously. Total cycle length (Tel) decreased and bec~me
constant from cycle to cycle indicating the increase in heart rate. Ejection time·
(EJT) was significantly decreased while both the average wall force developed .
. ~ .
within the left ventricle during ejection and the mean velocity of circumferential.
fiber shortening (mean V CF) increased.
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The greater stroke volume produced was achieved as a result of a greater rate
of ejection, an increase in myocardial contractility, and more systolic emptying
of the left ventricle as well as an increase in total peripheral resistance•. These.
were the primary causes for the significant increase in mean arterial pressure
produced by the injection of norepinephrine ..
Figure 12 shows a typical recording during a constant infusion of norepinephrine.
Norepinephrine Infusions at Constant Rates ...
Figure 13 shows the cardiac and circulatory effects of constant infusions of 0~25,
0.5, 1. 0, 2.0 and 3.0 micrograms/kilograms/minute of norepinephrine. At the
largest dose mean aortic pressure is increased 40% above the control level. This is
a typical response. The major effects of norepinephrine infusion are two: First
there is an increase in total peripheral resistance at each dose level, which reaches
55% at an infusion rate of 30AJgms/kg/min.; second the rate of rise of ventricular.
pressure (mm Hg/sec) divided by the developed pressure at 40 mm Hg (dP/dt/lvp
(40» increases significantly with each increase in dose level up to a value of 85% .
above control when the infusion rate is 3. O..AJgms/kg/min. This response is clearly
indicative of the potent effect of n.orepinephrine in causing peripheral arteriolar,
constriction and increasing myocardial contractility. It is believed that the former
is due to the alpha stimulating effect of norepinephrine while the latterisdue·"·
to b~ta receptor stimulating effect on ventricular myocardium. Norepinephrine
infustions at concentrations above O. 5AJgms/Kg/minute decreased left ventricular
-26-
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end-diastolic volume by 15 to 20% below control levels. This appears to be due
mainly to a decrease in venous return to the heart and is primarily a result of veno
constriction.
little change is seen in heart rate, especially at infusion levels above 1.0
.Algm/Kg/minute. Because of this, and since. stroke voJume(not shown) is slightly
decreased, cardiac output is below control value with infusions of norepinephrine-,·
concentrations above 1.0..ugm/Kg/minute•
The ability of the heart to maintain the elevated arterial pressure level in the .
presence of a signific:antly increased TPR while at the same time operate from a
smaller end-diastolic volume is due primarily to the increased myocardial contrac-
tility. This view is supported not only by the significant ir.crease in dP/dt/lvp (40)
but as well by the increased stroke work and stroke power which the ventricle
produces from smaller end-diastolic volumes at infusion rates of 2.0 and 3.0
..AIgms/Kg/minute.
Norepinephrine Infusions after Beta Receptor Blockade
The study of the effects of norepinephrine infusions on the heart and circulation
is greatly enhanced by the use of selected blockade of alpha or beta rec~ptors•.
We have used only beta receptor blockade in these studies. Figure 14 shows, in
the same animal, the effects of constanfinfusion of norepinephrine at different
dose_levels after nearly complete beta receptor blockade. To accomplish the block
propanolol was given in a dose of 0.5 milligrams per kilogram of body weight;
which dose effectively blocked all effects of a single intravenous injection of
-29-
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isoproterenol (12 mgms!kg), the classic beta stimulating drug.
A comparison of the effects of infusions of norepinephrine after beta blockade
.. (fig •. 14) with those seen before (described above) will reveal that the effects
produced by this drug are specifically a function of its beta receptor stimulating
··activity.
.Effects on TPR
Total peripheral resiStance is increased as much as 300% over control levels
at norepinephrine rates of 2. O.AJgms/Kg/minute after beta blockade (fig. 14)•
. This is to be compared with an increase in TPR of only 35% before blockade (fig. 13).
This ten fold difference is due mainly to the removal of the peripheral vasodilator
effect of nore·pinephrine before beta receptor blockade. In other words in the
normal "unblocked ll animal norepinephrine causes selective arteriolar dilation in
some vascular beds and constriction in others, consequently the net effect is a
lesser change in total peripheral resistance after a given dose of norepinephrine than
is the case when the same dose is given after beta blockade which removes the
vasodilator effect•
. Effects on Myocardial Contractility
An index of changes in myocardial contractility can be obtained by evaluating
the shift in the ventricular function curve with"various interventions. Typical ventri-
cular function curves are shown in figure 15. This shows a plot of the relationship.
between left ventricular end-diastolic volume (LVED) in milliliters (ml) and stroke
work (gm-m) in a co~scious dog (dog #117). The open circles plot the stroke work-
-31-
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ventricular end-diastolic volume relation for different end-diastolic volumes which
were produced by "pacing" the ventricle at different rates during .the control period
where the dog was standing quietly in a modified Pavlov stand. It is seen that the
larger the LVEDV the greater was the stroke work produced.
The triangles represent similarly acquired points except that the dog was under
the influence of the effects of norepinephrine which was continuously infused intra-
venously at a constant rate of 0.5 micrograms/kilogram/minute. Note that during
this period a much greater stroke work was produced from a given LVEDV than
was the case during the control period. This t1upward shift" in the lIven tricular
function curve" (the LVEDV/SVV relationship) gives a clear indication that myo-
cardial contractility was increased I That is, when the heart was under the influence
of an increased myocardial norepinephrine concentration produced by infusing this
catecholamine, a greater stroke work was produced when the heart contracted from.
any given end-diastolic volume than was present from that same end-diastolic
volume during the control period.
A similar type of change would be seen if stroke power instead of stroke work
had been plotted against end-diastolic volume.
There is one problem with using this type of shift in the ventricular function
curve to identify the presence of a change in myocardial contractility; that is the
fact that we have no knowledge about the levels of the aortic pressure during the
periods studied. It is well known that an increase in the mean aortic pressure will
have a depressant effect on the amount of stroke work the heart will perform from a
-34-
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given end-diastolic volume. Thus other indices must be used in addition to the
function curves to permit a more reliable evaluation of shifts in myocardial con-
tractility. It appears that the use of dP/dt/LlP (40) may be one such reasonably.
reliable indicator of change in myocardial contractility. That is the rate of rise
of ventricular pressure up to some value of developed pressure in the left ventricle,
which latter occurs c1ea~ly before the aortic valves open, is probably a reliable
indicator of the velocity of contractile element shortening within the ventricular
myocardium. Presumably the faster this velocity of contractile element shortening
during periods of assumed isometric contraction of the ventricle, the greater is the
myocardial contractility and vice versa.
Returning now to the effects on myocardial contractility produced by the nor"
epinephrine infusions, a quick comparison between the changes produced before
(fig. 13) and after beta blockade (fig. 14) reveals that beta receptor blockade
completely prevented any increase in dP/dt/L} P, whereas this variable was increased
as much as 75% above control values when 2.0 micrograms/Kg/min. of norepine-
. .
phrine was infused before propranolol was given.
It can be observed also that stroke work and stroke power were decreased by the'
norepinephrine infusions after beta blockade while similar infusions of norepinephrine
before propanolol increased stroke work and 'stroke power.
We learn from these observations first that norepinephrine increases myocardial
contractility and second that it produces the effect primarily by its beta receptor
stimulating effect, both of these observations are of course well known to you.
-35-
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Summary
Norepinephrine infusions are informative to us in understanding how alpha and
beta receptor stimulation affects cardiac performance. This drug increases total
peripheral resistance without increasing cardiac output, produces sufficient stroke
power to elevate the mean arterial pressure largely as a result of its ability to
increase myocardial contractility and at the same time caus~s the heart to operate
from a smaller end-diastolic volume. The latter is produced by norepinephrine'
decreasing venous return to the heart, which in .tum is due to venoconstriction and
vasodilation in the skeletal muscle vessels.
-36-
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Effect of Single Injection of Isoproterenol (O.4Agms;kg)
The classical response to a single injection of this drug is shown in figure 17.
The injection was made in the same conscious instrumented dog shown in figure 2
and into which the injection of norepinephrine was made that is shown in figure 1.0.
This record shows the increase in heart rate and peak dP!dt that regularly.
follows inj.ections of isoproterenol. Simultaneous with the~ ch<:Jnges in heart
rate and peak dP/dt both end diastolic and end systolic left ventricular internal
diameter (LVID) decreased as did left ventricular end-diastolic pressure.
Figure 18 shows the changes that occurred in selected variables that were
derived for every other cardiac cycle during the period of computer sampling
(as indicated at the bottom of figure 17).
The chosen variables are the same as those followed during the single
ejection of all the other drugs studied. The response to the injection of isoproterenol.
represents the effect of a practically pure beta adrenergic receptor stimulation.
Here (fig. 18) an increase in myocardial contractility is indicated by the rise·
in dP/dt!P and the fall in ejection time (EJT), the rise in mean velocity of·
circumfarential fiber shortening (mean VCF)-"
Typically isoprotarenol decreased markedly both end-diastolic and end-systolic
ventricular volumes yet there was only a slight decrease in mean~ortic pressure.•.
Effect of Constant Infusions of Isoproterenol
The cardiac and vascular response to constant infusions of isoproterenol at
-38-
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dose levels of 1.0, 2.0, 3.0 and 4. O,Agms;kg/min are shown in figure 19.
Isoproterenol has a powerful beta receptor stimulating action with almost no
action on alpha receptors. As such, its main actions are o~ the heart where it
increases myocardial contractility, on the skeletal muscle vasculature where it
causes vasodilation, and on the smooth muscles of the bronchi and the gastro-
intestinal tract which it relaxes.
It can be seen thru study of figure 19 that mean aortic pressure falls to about
20ek below control levels at all dose levels infused. The most striking effects
are those of increasing heart rate, cardiac output and dP/dt/L.\P (an index of
increased myocardial contractility) •
.. End-diastolic volume is decreased at all dose levels while at the same time
stroke power is significantly elevated above control value. These observations
indicate a shift of the relationship between left ventricular end-diastolic volume
and stroke power such that the heart is producing more stroke power from a
significantly decreased end-diastolic volume where it isunder the influence of
isoproterenol than was produced from the much larger end-cliastolic volumes
during the control periods.
It is of great interest that stroke work is reduced by the isoproterenol infusions.
The major effect of isoproterenol is to cause the heart to effectively and signifi-
cantly increase its cardiac output, and stroke power while operating from a smaller
end-diastolic volume and at the same time reduce its stroke work. Thus a
significant improvement in cardiac performance is achieved largely as the result
of an increase in heart rate and myocardial contractility without a drastic drop
in mean arterial pressure.
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ANGIOTENSIN II
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Effect of single injection of angiotensin II (0. 12 Agms/Kg)
A typical analog recording of the changes occurring in aortic pressure
(AP), left ventricular pressure (lVP), left ventricular internal diameter (lVID) .
and the left ventricular electrogram (lVEG) in response to a single intravenous
injection of O. 12 .Agm/kg into a conscious instrumented dog is shown in figure 20.
Figure 2l shows the plot of the variables, the maximum rate of rise of left ventri-
cular pressure at ~ developed ventricular pressure of 40 mm Hg (dP/dt/~(40»'
stroke power (SP), total cycle length (TCl), stroke volume (SV), mean aortic
pressure (MAP),. stroke work (SW), left ventricular end-diastolic pressure (lWEDP), .
left ventricular'volume (lV Vol) where the open circles represent end-diastolic
volume and the closed circles represent end-systolic volume, ejection time (EJT),
average wall force during ejection (AWF), and mean velocity of circumferential
fiber shortening (mean VCF). Each point represents in sequence every other
cardiac cycle starting with the 70th cardiac cycle analyzed by the digital com-
puter. The sampling period is shown at the bottom of figure 15.
Thus figure 21 displays the variables listed above for every other cardiac
cycle occurring in figure 20. during the period of the computer sampling.
The angiotensin II injection caused an increase in mean aortic pressure that
was unaccompanied by a change in myocardial contractility since neither dP/dt/P
nor stroke work nor left ventricular end-diastolic volume changed significantly.
-44-
Also ejection time was not reduced by the injection of angiotensin II.
Stroke power wc:is increased suggesting that the left ventricle was able to
generate more stroke power from a given end-diastolic volume as a result of
.the angiotensin injection.
It appears that this single injection of angiotensin II had its primary effect
thru increasing total peripheral resistance with little or no effect on myocardial
contractility•
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Effect of constant infusions of angiotensin II
The typical effect of constant infusion of angiotensin II on cardiac function
when given to a conscious dog at dose levels of 0.2, 0.4, 0.6, and 0.8 Agm¥ksl
min. are shown in figure 22 where each increment in dose level angiotensin
increased further total peripheral resistance and aortic pressure. Left ventricular
end-diastolic volume was increased and as a result both stroke work and stroke
power were also elevated; dP/dt/P was not changed indicating no change in·
myocardial contractility.
We may conclude from the observations that with angiotensin II infusion
in conscious animals arterial pressure is elevated primarily by virtue of its effect
. in constricting the peripheral arterioles and thus increasing total peripheral
resistance. The reduced cardiac output is produced primarily as a result of the
decrease in heart rate which is reflexly produced as a consequence of the elevated
arterial pressure activating the mechanoreceptors in the walls of the aortic arch'
and carotid sinuses•. The increases in stroke work and stroke power apparently.
are brought about through the operation of Starling's Law since these increases
parallel the increases in end-diastolic volume which accompanied each increase
in dose level of angiotensin II that was infused.
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PHENYLEPHRINE
Section IV
...
-50-
I
I
Effect of Constant Infusions of Phenylephrine
The study of the effects of infusions of phenylephrine at different dose levels
allow for the analysis of the cardiovascular response to a practically pure alpha
receptor stimulating substance. and is to be contrasted to the effects of infusions
of isoproterenol, a practically pure beta receptor stimulating substance. Again
the chosen variables for"study are the same as those discussed for all the previous
dogs.
Figure 23'shows the response to infusions of 60, 80, and 100 )lgms;Kilogram!
minute of phenylephrine, in terms ofthe percent change from the control level for
each variable.
At the infusion rate of 100jtgms/Kg/min a significant increase in total
peripheral resistance (TPR) was produced and this is the expected effect of
peripheral arteriolar constriction due to alpha receptor stimulation. Of. particular
importance is the observation that little or no change occurred in end-diastolic
volume, stroke work, stroke power or dP/dt/P wah infusions at any of the three
dose levels. This shows that the rise in aortic pressure was primarily the result
of arteriolar constriction and no change was produced by the drug in myocardial
contractility. Heart rate was reduced at the highest dose level and as a result
so was cardiac output. The reduction in he~rt rate was largely due to elevation
in aortic pressure, which reflexly, via the aortic and carotid sinus mechano-
receptor reflex mechanisms, caused an increase in vagal impulses to the heart.
This response of the heart and circulation to phenylephrine administration
resembles quite closely the effect of norepinephrine administration in animals
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who have their beta receptors blocked by use of propranolol or some other
"beta blocking agent lJ 0
- " ",: ~'.. '.
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Section V
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GLUCAGON
. I
I
!
Glucagon: A potentially useful agent in cardiac therapy·
Glucagon is a polypeptide honnone produced primarily by the alpha cells
of the pancreas. It's primary physiologic role appears to be to promote hepatic
glycogenolysis and increase blood glucose levels. These effects are just the
opposite of the effects of insul in.
Glucagon has been shown to exert significant effects upon the cardiovascular
system. These effects are mediated through glucagon's ability to increase cyclic
adenosine monophosphate through activation of the enzyme adenyl cyclase.
Some of these effects on the cardiovascular system are described below.
Experimental Observations
. Table 1 shows the effect of glucagon on ventricular rate (VR), and cardiac
output (CO), and mean arterial pressure (MAP) during sinus rhythm and during
atrial fibrillation. In both conditions the heart rate and CO are clearly increased
The effects of glucagon on ventricubr rate (VR), end-diastolic volume (EDV),
stroke work (SoN), tension time index (TTl); and ejection fraction is shown in table 2
both during sinus rhythm (SR), and atrial fibrillation (A. Fib,). It can be seen that
glucagon(50 micrograms per kilogra~ results in a significant increase in ventricular
rate and stroke work without a significant change in EDV.
TABLE 2
Vent. Rate* EDV SoN TTl Ejected
beats/min. (ml) (gm-m) (per min) fraction (%)
66 + 17 52 +2 35 +3 1717 50 + 1
Status
Sinus Rhythm
Sinus Rhythm
After Glucagon 50
microgm/Kg
Atrial Fibrillation
Atrial Fibrillation
After Glucagon
(50 microgm/Kg) .
93 *22
88 +32
··325 +31
51 +2
51 +3
25+6
44 +4
31 +6
18 +11
1632
1971
2964
57 +2
51 +7
21 +23
* values are mean + SO
The effect of glucagon in increasing myocardial contractility in the awake
conscious dog is shown in table 3. The effect of an intravenous bOlus injection of
glucagon was manifest in 30 seconds and reached a maximum in 1 or 2 minutes and
lasted for 10-15 minutes. An increase in dP/dt, dP/dt over developed pressure and·
mean velocity of circumferential fiber shortening was noted. This clearly indicates
that myocardial contractil ity was increased.
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Effect During Spontaneous Atrial Fibrillation
Table 4 shows the effect of various drugs on the ventricular response inatrial
fibrillation compared to glucagon.
There isa,slight slowing after ouabain arid a slight increase in rate after nore-
pinephrine. Cardiac sympathetic blockade with atropine and propanolol resulted
in an increase in ventricular rate to 190 beats per minute from a control of 97.
The administration of glucagon resulted in a dramatic rate increase to 340 beats
per minute.
Glucagon results in significant enhancement in ventricular performance. This
has proved useful in the treatment of cardiac failure especially when induced by
propanolol since glucagon effects are not blocked by propanolo!. However, the
data in dogs suggest that the administration of glucagon during atrial fibrillation may
be hazardous.
-58-
Selected References
1. Ahlisquist, R. P.: A study of adrenotropic receptors. Amer J. Physiol. 153:
586-600, 1948.
2. Goodman, L. S. and Gilman, A.: The pharmacological basis of therapeutics,
(fourth ed) The MacMillian Co., 866 Third Avenue, N. Vo, N. V., 197J.
3. Berne, R. M. and Levy, M. N.: Cardiovascular Physiology, (second ed).
The C. V. Mosby Co., 1972.
4. Hawthorne, E. W.: Symposium on measurement of left ventricular volume.
Part III. Dynamic geometry of the left ventricle •. Amer. J. Cardiol. 18:
566-573, 1966.
6. Hinds, J. E., Hawthorne, E. W., Mullins, C. B. and Mitchell, J. E.:
Instantaneous changes in left ventricular lengths occurring in dogs during the
cardiac cycle. Federation Proc. 28: 1351-1357, 1969.
7. Hunter, F. K., Cothran, L. N., Hawthorne, E. W.: The mechanical charac-
teristics of hypertrophied heart muscle. In: Cardiac Hypertrophy, N. Alpert,
ed. New York: Academic Press, 1971.
8. Hawthorne, E. W. and Kraft-Hunter, F.: Current approaches to the study of
the dynamic geometry of the left ventricle in conscious dogs. In: Hibernation-
Hypothermia Perspectives and challenges, Amsterdam: Elsevier Publishing Coo,
1972, p. 457-480. -
-59-
IV. Further Development of Data Acquisition and Reduction Techniques with the
Aid of a Small Dedicated Computer System.
The basic format and approaches we used in developing this system are described
in our grant application in a section titled "A User Interactive Data Acquisition and .
- Reduction System for the Study of Cardiac Dynamics" •. , In addition we have published
this information. (See publications section below).
Certain unique features of the system have been developed during the past year.
These are:
A. Development of the .capacity to take and analyze long samples (up to 4 minutes) •
.B. Development of programs to display plots of data.
C. Development of programs which permit plots of:
1. Histograms
2. Serial autocorrelograms
3. Spectral density plots
4. x-v plots of any desired derived or primary variable against another
I
The capacity for analyzing up to four (4) minutes worth of data has been extremely
helpful. This capability permits the investigator to request the A-D converter to
sample simultaneously up to six (6) simultaneous recorded analog signals. Ordinarily
we monitor dP/dt, aortic pressure, left ventricular pressure, left ventricular intern'al
diameter, left ventricular length and the ventricular-electrogram at either 2, 5, or
10 millisecond intervals for periods of from seven (7) seconds up to four (4) minutes
if a five (5) msec. sampling rate is used. This program then will identify all the
individual cardiac cycles in the sample and analyze each one producing a listing
of all the desired information. In addition it will provide the means and standard
deviations for each variable. Figure 24 shows a copy of one "printout" of this type.
In this case it can be seen that the means and S. D. 's for a sample consisting of
307 consecutive cardiac cycles is provided. This sample was taken while monitoring
the effects of LBNP (-40 mm Hg) on a conscious instrumented dog after beta blockade.
The remaining figures (25,26,27,28)are samples of various computer generated
plots.
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·v. Development of a Totally Implantable Telemetry Package
Development of primary objectives in this area have proceeded through the joint
efforts of Dr. Sandler and his group and our research group. A satisfactory design has
_ been developed for these implantable biosensors and a contract has been made with
Konigsberg Instrument Company to build these units for us. A recent manuscript
published by Dr. Sandler (Sandler, H., Stone, H. L, Fryer, T. B. and Westbrook,
R. M.: Use of Implantable Telemetry Systems for Study of Cardiovascular Phenomena~
Circulation Research Suppl. II, 30-31: 11-85, 1972) describes the basic system
we hope to employ. Oursystem will have additionally an inductance micrometry channel
to pennit the recording of changes in left ventricular internal diameter. Test models
of our telemetry units are still on the workbench, and receiving dates have been
pushed back; we are hopeful that by late November they will have been received.
Our intent is to test these systems in dogs in the late fall of this year and by early
spring 1973 to implant and test these Biotelemetry Packs in chimpanzees.
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